Abstract
The spread of antimicrobial resistance among members of the Enterobacteriaceae is a significant clinical threat. We report the treatment of pan-resistant Klebsiella pneumoniae bacteraemia with combination tigecycline and colistin in a 49-year-old male and review available therapeutic options. Despite a poor prognosis, the patient recovered, but remains colonized with the pan-resistant isolate.
MeSH terms
-
Animals
-
Anti-Bacterial Agents / administration & dosage*
-
Anti-Bacterial Agents / pharmacology
-
Bacteremia / complications*
-
Bacteremia / diagnosis
-
Bacteremia / drug therapy
-
Colistin / administration & dosage*
-
Drug Resistance, Multiple, Bacterial
-
Drug Therapy, Combination / methods
-
Humans
-
Klebsiella Infections / complications*
-
Klebsiella Infections / diagnosis
-
Klebsiella Infections / drug therapy
-
Klebsiella pneumoniae / isolation & purification*
-
Male
-
Microbial Sensitivity Tests
-
Middle Aged
-
Minocycline / administration & dosage
-
Minocycline / analogs & derivatives*
-
Pneumonia, Bacterial / complications*
-
Pneumonia, Bacterial / diagnosis
-
Pneumonia, Bacterial / drug therapy
-
Tigecycline
Substances
-
Anti-Bacterial Agents
-
Tigecycline
-
Minocycline
-
Colistin